Medifast (MED) Appoints Michael McDonald as CEO
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.67 +4.80%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 8.2%
Revenue Growth %: -24.3%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 8.2%
Revenue Growth %: -24.3%
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED),has named Michael C. MacDonald, Executive Chairman of the Board, as the Company's new Chief Executive Officer, effective February 8, 2012. In addition, upon expiration of Michael S. McDevitt's employment agreement on February 8, 2012, the Company and Mr. McDevitt have mutually agreed to the separation of his employment as Medifast's Chief Executive Officer and Director, effective February 8, 2012.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lowe's names five executive vice presidents effective Sept. 1
- BP plc (BP) Names Ian Tyler Chair Effective Immediately
- OptimizeRx names former J&J data science officer as company advisor
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
